INTS vs OKE
Intensity Therapeutics, Inc. Common stock (INTS) versus ONEOK Inc (OKE) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
INTS does not have a complete income-statement cache yet.
Latest reported OKE revenue for 2024-12-31 was $21.70B. Net income was $3.11B. Revenue was up 22.7% from 2023-12-31 to 2024-12-31. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
INTS currently screens at market cap $7.7M. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Not investment advice. Open the INTS and OKE stock pages for the full models.
Not investment advice.